Login / Signup

Phase I/II study of carfilzomib, bendamustine, and dexamethasone (CBD) in patients with newly diagnosed multiple myeloma.

Siyang LengDivaya BhutaniShahzad RazaAmer AssalSamuel PanJianhua HuAlexander WeiMarkus MaparaSuzanne Lentzsch
Published in: Blood cancer journal (2020)
Keyphrases
  • multiple myeloma
  • newly diagnosed
  • low dose
  • high dose
  • chronic lymphocytic leukemia